Background and Purpose: Arachidonate metabolites have been implicated in the development of cerebral injury after ischemia. Particular importance has been placed on the balance of thromboxane A2 and prostaglandin 12 because of its regulative activity on platelet functions and arterial tone. The purpose of the present study was to shed light on the role of thromboxane A2 in postischemic brain injury.
See Editorial Comment, page 2064 of thromboxane synthase inhibition in animal models of brain ischemia. [21] [22] [23] [24] (+)-(5Z)-7-[3-Endo-[(phenylsulfonyl) amino]bicyclo-[2.2.1]hept-2-exo-yl]heptanoic acid (S-1452) is a stable calcium salt of the (+)-isomer of S-145 that has been shown to be a potent and selective TXA2 receptor antagonist. S-145 has been found to be an effective blocker of TXA2-induced platelet aggregation and vasoconstriction and to protect against collagen-induced ECG changes and thrombopenia and experimental bronchial asthma in rodents. [25] [26] [27] [28] [29] [30] Permanent middle cerebral artery (MCA) occlusion models in the rat have generally been used to assess the protective effects of various drugs against ischemic brain damage.31'32 However, in human ischemic stroke, there is a possibility that recirculation occurs frequently after focal ischemia, particularly in the case of cerebral embolism. Thus, a recirculation model after MCA occlusion may be useful for simulating focal ischemia in humans. In the present study, we used a transient MCA occlusion model in the rat that is produced by inserting a silicon-coated nylon thread from the external carotid artery (ECA) into the internal carotid artery (ICA). This MCA occlusion model is relatively simple and easy to reperfuse.
The aim of the present study was to shed light on the role of TXA2 in postischemic brain injury. Thus, we evaluated the effects of S-1452 on brain edema, infarct areas, and survival rate in the rats with a transient right MCA occlusion.
Materials and Methods
We induced transient focal ischemia by right MCA occlusion in male Wistar rats by the modified method of Longa et al. 33 Adult male Wistar rats (270 to 320 g) that were specific pathogen free were anesthetized with a gas mixture of 70% N20-30% 02-2% halothane. After a median incision of the neck skin, the right ECA was carefully dissected, and an 18-mm-long 4- Approximately 30% of the experimental animals were excluded by the above reasons, and the rest (approximately 70%) of the experimental animals were used as ischemic animals in further study.
After 1 or 2 hours of MCA occlusion, the thread was removed to allow complete reperfusion of the ischemic area via the right common carotid artery (CCA).
Rats were decapitated at 0 hour (just after reperfusion), 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours after reperfusion following 1-hour transient MCA occlusion. For measurement of brain water content, brain samples of both hemispheres were taken from the cerebral cortex perfused by the anterior cerebral artery (ACA area), the cerebral cortex perfused by the MCA (MCA area), and the caudate putamen. The water content of these samples was calculated as follows: 100x (wet weight-dry weight)/wet weight (%). MCA and ACA areas were defined as described by Nagasawa and Kogure.34 Before the experiment, the extent of the ischemic area was clarified by transcardiac perfusion of three ischemic animals with carbon black. The colorless area was considered to correspond to the territory supplied by the occluded MCA. The cerebral cortex corresponding to the colorless area was taken as MCA area, and the remainder of the cortex was taken as ACA area from both hemispheres.
Before decapitation, blood was drawn from the right jugular vein to measure plasma TXB2 and 6-keto-PGF,a. The blood in a tube containing ethylenediaminetetra-acetic acid (EDTA) and indomethacin was centrifuged at 2000g for 10 minutes at 4°C. A mixture of 0.95 mL of an EDTA solution (2% disodium EDTA and 0.8% NaCI adjusted to pH 7.4 with NaOH) with 0.05 mL of a 0.04 mol/L indomethacin solution dissolved in absolute ethanol was used for the treatment of 10 mL of blood. The plasma samples were frozen with dry ice powder immediately after separation and then stored at -80°C until the measurement of TXB2 and 6-keto-PGFi,. Brain water content and plasma TXB2 and 6-keto-PGF,a in complete sham-operated rats also were measured (represented as normal in results and figures).
Radioimmunoassay of TXB2 and 6-keto-PGFIa was conducted after extraction of the plasma. The plasma was acidified to pH 3.0 with 1N HCl and loaded on a Amprep C2 100-mg column (Amersham, UK), which was washed with 2 mL of 100% methanol and 2 mL of water before use. Next, the column was washed successively with 5 mL of water, 5 mL of 10% ethanol, and 5 mL of hexane. Prostanoids were finally eluted with 5 mL of methylformate. The eluant was evaporated under a stream of nitrogen gas at room temperature, and the residue was dissolved in assay buffer solution that consisted of 0.1% gelatin and 0.01% thimerosal in 0.05 mol/L phosphate buffer (pH 7.3). TXB2 and 6-keto-PGF,a were analyzed by radioimmunoassay using kits from Amersham: TXB2 (no. RPA 516; threshold of detection, 20 pg/mL) and 6-keto-PGFi, (no. RPA 515; threshold of detection, 20 pg/mL).
To assess the contribution of TXA2 to postischemic brain edemas and infarct areas, rats were administered S-1452 (5, 10, and 50 mg/kg PO) 15 minutes before 1-hour transient MCA occlusion. Brain water contents 24 hours after reperfusion were measured by the dryweight method described above. To measure infarct areas, rats were perfused with heparinized physiological saline 24 hours after reperfusion. The brains were removed from skulls, cut into 1-mm coronal sections, and immersed in 2% triphenyltetrazolium chloride (TTC) solution at 37°C for 30 minutes. 35 The areas colorless to TTC staining, which reflect mitochondrial damage, were quantified as infarct areas by an imaging analysis system (Kontron M14. Zeiss, West Germany).
The survival of animals treated with S-1452 or vehicle (0.5% calboxymethyl cellulose) alone was compared at the time points of 3, 6, 12, 24, 48, and 168 hours after reperfusion following 2-hour transient MCA occlusion. The mortality of animals was approximately 60% at 168 hours after reperfusion following 2-hour occlusion, but 1-hour occlusion was a nonlethal ischemia. Then, we used 2-hour MCA occlusion to evaluate the effect of S-1452 on the survival rate after transient cerebral ischemia. Rats were administered S-1452 (10 mg/kg PO) 15 (Fig 1) . However, increase of water content in the ACA areas was also significant but minimal (nonoccluded side, 79.09+0.13%; occluded side, 80.33±0.26%; P<.01 at 24 hours after reperfusion; Fig 1) .
The level of plasma TXB2, a stable metabolite of TXA2, significantly increased from 92.8±20.4 pg/mL (normal) to a maximum of 369.8±67.2 pg/mL (P<.01) at 0 hour (just after reperfusion), 219.4±38.7 pg/mL (P<.05) at 1 hour, and 212.7±30.0 pg/mL (P<.05) at 12 hours and nearly returned to the normal level by 24 hours after reperfusion. The level of plasma 6-ketoPGFi,, a stable metabolite of PGI2, was almost unchanged but slightly increased from 54.1±4.6 pg/mL (normal) to 81.6±8.9 pg/mL (P<.05) at 0 hour and 76.2±6.7 pg/mL (P<.05) at 6 hours after reperfusion (Fig 2) .
In addition, the ratio of plasma TXB2 to 6-keto-PGFla significantly rose from 1.73±0. 40 hours after reperfusion (Fig 2) . The elevation of the ratio until 3 hours after reperfusion was noteworthy. The effect of S-1452 on brain edema after transient focal ischemia is shown in Fig 3. Animals administered S-1452 (5, 10, or 50 mg/kg PO) 15 (Fig 4) .
The effect of S-1452 (10 mg * kg-1 . d-l Po) on the survival rate of animals after 2 hours of MCA occlusion is shown in Fig 5. At 3, 6 Time after reperfusion (hr)
FIG5. Plotofeffectof S-1452 (10mg *kg-d-'PO) on survival rate of animals at various times after reperfusion following 2-hour middle cerebral artery occlusion. Although there was no statistical significance by Fisher's exact probability test, the survival rate tended to be improved in S-1452-treated animals. In our studies, S-1452 significantly suppresses the elevation of water content in the cerebral cortex after reperfusion following transient ischemia. However, suppression of the water content elevation by S-1452 is slight in the caudate putamen. Moreover, improvement of the infarct areas by S-1452 after focal ischemia is restricted in only the front parts of the cerebrum. The caudate putamen and the hind parts of the cerebrum are areas that become the ischemic core by MCA occlusion. On the other hand, we consider that the cerebral cortex and the front parts of the cerebrum are the ischemic penumbra areas or the areas that are easily perfused by collateral blood flow such as from the ACA. Pettigrew et a124 has reported that TXA2 synthase inhibition suppressed the elevation of the ratio of cerebral TXB2 to 6-keto-PGFl,a and enhanced the cerebral blood flow after reperfusion following cerebral ischemia. 24 In our ischemia models, S-1452 may retard the vasoconstriction that would contribute to depression of the cerebral blood flow during ischemia and reperfusion. Alternatively, S-1452 may prevent microvascular occlusion by inhibiting secondary aggregation of platelets stimulated by toxic products released during ischemia. We suppose that TXA2 synthetase inhibitors and TXA2 receptor antagonists such as S-1452 can alleviate brain injury after transient ischemia not by direct effects on the neurons but rather by the increase of collateral blood flow through its antiplatelet and vasodilating activities, which are particular to the ischemic penumbra.
Other investigators also described the beneficial effects of thromboxane system inhibition in animal models of brain ischemia. Sadoshima et a143 performed bilateral CCA occlusion on spontaneously hypertensive rats given the TXA2 synthetase inhibitor OKY-046 and found significant increases in the cerebral blood flow and improvements of cerebral glucose metabolism during ischemia. Roy et a123 reported that reduced TXB2 levels due to TXA2 synthetase inhibition correlated with increased regional cerebral blood flow in the ischemic penumbra in cats with a permanent MCA occlusion. Their findings suggest that thromboxane synthase inhibition may be important for the preservation of neurons threatened but not destroyed by hypoperfusion.
On the other hand, platelets may adhere to the damaged endothelium and subendothelium due to ischemia and release vasoactive substances that promote platelet aggregation and vasoconstriction.38 There is increasing evidence that platelets play an important role in the development of injury after SAH.8, 9 We consider similar mechanisms to be involved in the development of cerebral injury after reperfusion following ischemia.
In conclusion, we have demonstrated that ratios of rat plasma 
Editorial Comment
The role of the microcirculation in cerebral ischemia is just beginning to attract widespread attention. There has been some research in such issues as reperfusion injury and the effects of leukocytes, but these have mostly been considered laboratory curiosities with little clinical relevance. Evidence is now accumulating that damage at the microcirculatory level can be therapeutically altered. Especially for embolic strokes, there is considerable reason to suspect that spontaneous thrombolysis occurs frequently. Furthermore, if thrombolytic therapy is proven to be effective, the problems associated with reperfusion will assume increased importance.
